FARMAÈ GROUP: CONSIDERABLE GROWTH IN THE THIRD QUARTER 2022 CONSOLIDATED REVENUES AT €28.4 MILLION, UP 58.3% YOY AND 17.7% YOY ON A LIKE-FOR-LIKE BASIS
19/10/2022
11:55
THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED HALF-YEAR FINANCIAL REPORT AS AT 30 JUNE 2022
26/09/2022
14:23
FARMAÈ GROUP: CONSOLIDATED REVENUES OF 52,5 MILLION EURO IN THE FIRST HALF OF 2022 AND OF 27,2 MILLION EURO IN THE SECOND QUARTER OF 2022
22/07/2022
12:59
FARMAÈ GROUP: CONSOLIDATED REVENUES OF 25.5 MILLION EURO IN THE
FIRST QUARTER OF 2022
20/04/2022
15:02
FILED A LIST FOR THE APPOINTMENT OF THE BOARD OF DIRECTORS AND A PROPOSED RESOLUTION WITH REFERENCE TO THE DETERMINATION (I) OF THE DURATION OF THE B.O.D.; (II) OF THE NUMBER OF MEMBERS OF THE B.O.D. AND (III) OF THE TOTAL FEE FOR ALL MEMBERS OF THE B.O.D. (INCLUDING THOSE INVESTED IN SPECIAL OFFICES)
19/04/2022
19:17
THE BOARD OF DIRECTORS APPROVES THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT 31 DECEMBER 2021 DRAFTED FOR THE FIRST TIME IN ACCORDANCE WITH INTERNATIONAL ACCOUNTING STANDARDS
31/03/2022
07:54
THE BOARD OF DIRECTORS OF FARMAE’ S.P.A. APPROVES THE SHORT-TERM CASH INCENTIVE PLAN – MBO PLAN 2022
11/03/2022
11:48